Chamaejasmenin A(89618-14-4)
- Name: Chamaejasmenin A
- Synonyms:(2S,3S,2'S,3'S)-5,7,5',7'-Tetrahydroxy-2,2'-bis-(4-methoxy-phenyl)-2,3,2',3'-tetrahydro-[3,3']bichromenyl-4,4'-dione;
- Molecular Formula:C32H26O10
- Molecular Weight:570.54
- CAS Registry Number:89618-14-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 32416-20-9/N-(3-Morpholinopropyl)-p-(propoxy)thiobenzamide
- 224566-10-3/Stigmasta-7,24(28)-dien-29-oicacid, 2,3,11,14,20,22,25-heptahydroxy-6-oxo-, g-lactone, (2b,3b,5b,11a,22R)- (9CI)
- 58070-86-3/Benzoic acid, 3,3-(iminobis(sulfonyl))bis-, dimethyl ester, sodiumsalt, polymer with 2,2-(1,4-cyclohexanediylbis(oxy))bis(ethanol) and diethyl 3,3-(1,4-phenylene)bis(2-propenoate)
- 140221-76-7/Spiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2'-[2H]pyran]-20-one,13-[[5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3',3a,4',5',6,6',7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,17,27a-hexahydroxy-6'-(2-hydroxybutyl)-2,2,5',11,15,17,28-heptamethyl-(9CI)
- 153415-37-3/b-D-Glucopyranoside,(1R,2S,4aR,4bS,7S,10aR)-7-[1,2-dihydroxy-1-(hydroxymethyl)ethyl]-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1-(hydroxymethyl)-1,4a-dimethyl-2-phenanthrenyl(9CI)
- 139886-06-9/(E)-N-methoxy-1-[1-(propan-2-yl)-1,2,5,6-tetrahydropyridin-3-yl]methanimine hydrochloride (1:1)
- 17301-81-4/brucine N-oxide hydrate
- 22212-56-2/BENZOYLPROP
- 67401-55-2/[2,4'-Bithiazole]-4-carboxamide,2'-[14-ethylidene- 9,10,11,12,13,14,20,21,27,28-decahydro- 11,28-bis(1-hydroxyethyl)-21-(1-methylethyl)- 9,12,19,26-tetraoxo-19H,26H-8,5:18,15:- 25,22:32,29-tetranitrilo-5H,15H-pyrido[3,2-m]- [1,11,17,24,4,7,20,27]tetrathiatetraazacyclotriacontin- 2-yl]-N-[1-[[(2-oxopropyl)amino]- carbonyl]-1-propenyl]-
- 77680-31-0/Poly(oxy-1,2-ethanediyl), omega-hydroxy-omega-((1-oxo-2-propenyl)oxy)-alpha,alpha-((dodecylimino)di-2,1-ethanediyl)bis-, potassium salt
- 6947-54-2/N-[(2-methoxyphenyl)carbamoyl]octadecanamide
- 40496-48-8/(8-hydroxy-2-azabicyclo[3.3.1]non-2-yl)(phenyl)methanone
- 7235-52-1/dihydroxy-oxo-ammonium, ethanol, 6-[(isopropylamino)methylene]cyclohexa-2,4-dien-1-one, nickel
- 167425-77-6/2,12:7,12a-Dimethano-12aH-benzo[6,7]cycloocta[1,2-b]pyran-6(2H)-one,7,12-dihydro-7,9,10-trihydroxy-3-(3-hydroxy-2,4-dimethoxyphenyl)-14-[(4-hydroxy-2-methoxyphenyl)methyl]-,(2R,7R,12S,12aS,14R)-rel- (9CI)
- 63868-48-4/17-methyl-17-(2-phenylethyl)morphinan-17-ium-3-ol bromide
- 41896-78-0/FMC 23488
- 104807-41-2/BHC-9C
- 64290-27-3/potassium 6-methyl-2-(10H-phenothiazin-2-yl)quinoline-4-carboxylate
- 2941-72-2/6-METHOXY-2-METHYLBENZOTHIAZOLE
- 89618-14-4/Chamaejasmenin A
- 131929-08-3/diethyl 7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3,4-dicarboxylate
- 22569-72-8/Arsenide
- 46845-76-5/Ethylamine, N,N-dimethyl-1-(2-methyl-1,2-dicarbadodecaboran(12)-1-yl)-
- 14700-08-4/Stibine, stannyl-(8CI,9CI)
- 63194-78-5/6-(4-methoxybenzyl)-1,3-benzodioxol-5-ol
- 90932-07-3/6-(4-Morpholinyl)-3(2H)-pyridazinone (1-methyl-2-(4-morpholinyl)ethylidene)hydrazone
- 29822-05-7/ethyl 5-oxo-1-phenyl-4-{(E)-[4-(pyrimidin-2-ylsulfamoyl)phenyl]diazenyl}-4,5-dihydro-1H-pyrazole-3-carboxylate
- 7359-72-0/2,3,4-Trichlorotoluene
- 66081-37-6/TUNICAMYCIN A1 HOMOLOG
- 30251-62-8/1-(4-bromobenzylidene)-1H-indene